Open Access Pre-publication history

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

Mark J McKeage*, Michael B Jameson, Ramesh K Ramanathan, Joseph Rajendran, Yongchuan Gu, William R Wilson, Teresa J Melink and N S Tchekmedyian

BMC Cancer 2012, 12:496 doi:10.1186/1471-2407-12-496

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 02 Jul 2012
Resubmission - Version 2 Manuscript 02 Jul 2012
Reviewer's Report William Schelman 27 Aug 2012
Reviewer's Report James Cleary 04 Sep 2012
Reviewer's Report Wan-Teck Lim 04 Sep 2012
Resubmission - Version 3 Manuscript Author's comment 03 Oct 2012
Resubmission - Version 4 Manuscript Author's comment 18 Oct 2012
Editorial acceptance 23 Oct 2012
Published 25 Oct 2012